Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calpro is a Norwegian diagnostics company focused on calprotectin-based testing for intestinal inflammation, especially inflammatory bowel disease. The company develops, manufactures, and distributes laboratory ELISA assays, sample extraction devices, and rapid tests for clinic and home use. Its products are used to help differentiate inflammatory bowel disease from irritable bowel syndrome and to monitor disease activity, relapse risk, and treatment response. Calpro is particularly known for its CalproLab and CalproSmart product lines, including smartphone-enabled self-testing and remote monitoring tools. The company appears to operate as a private, active healthcare company with a commercial product portfolio rather than a therapeutics pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calpro.